Supriya Lifescience Limited (SUPRIYA.NS)

INR 698.8

(3.55%)

EBITDA Summary of Supriya Lifescience Limited

  • Supriya Lifescience Limited's latest annual EBITDA in 2023 was 1.83 Billion INR , up 25.0% from previous year.
  • Supriya Lifescience Limited's latest quarterly EBITDA in 2024 Q2 was 672.35 Million INR , up 3.81% from previous quarter.
  • Supriya Lifescience Limited reported an annual EBITDA of 1.38 Billion INR in 2022, down -37.25% from previous year.
  • Supriya Lifescience Limited reported an annual EBITDA of 2.21 Billion INR in 2021, up 23.81% from previous year.
  • Supriya Lifescience Limited reported a quarterly EBITDA of 625.42 Million INR for 2024 Q1, up 12.27% from previous quarter.
  • Supriya Lifescience Limited reported a quarterly EBITDA of 474.09 Million INR for 2023 Q1, down -16.84% from previous quarter.

Annual EBITDA Chart of Supriya Lifescience Limited (2023 - 2017)

Historical Annual EBITDA of Supriya Lifescience Limited (2023 - 2017)

Year EBITDA EBITDA Growth
2023 1.83 Billion INR 25.0%
2022 1.38 Billion INR -37.25%
2021 2.21 Billion INR 23.81%
2020 1.78 Billion INR 63.55%
2019 1.08 Billion INR 55.03%
2018 724.67 Million INR 219.0%
2017 266.81 Million INR 0.0%

Peer EBITDA Comparison of Supriya Lifescience Limited

Name EBITDA EBITDA Difference
Biocon Limited 41.52 Billion INR 95.579%
Blue Jet Healthcare Limited 2.29 Billion INR 19.916%
Concord Biotech Limited 4.65 Billion INR 60.598%
Dishman Carbogen Amcis Limited 3.07 Billion INR 40.238%
Jubilant Ingrevia Limited 4.56 Billion INR 59.779%
Lyka Labs Limited 167.58 Million INR -995.395%
Panacea Biotec Limited -47.58 Million INR 3958.262%
Piramal Pharma Limited 13.05 Billion INR 85.939%
SMS Lifesciences India Limited 349.41 Million INR -425.389%
Syngene International Limited 10.84 Billion INR 83.076%
TAKE Solutions Limited -1.05 Billion INR 274.695%
Zota Health Care Limited 82.07 Million INR -2136.742%